18.11.2022Michael Krauthammer and collaborators publish a perspective paper on the use and ethics of Digital Twins in medicine

The Use and Ethics of Digital Twins in Medicine

This work introduces both the concept and use cases of digital twins in medicine, frames the debate on their ethical, legal and societal implications through the lens of related health digital technologies, machine learning and personalized medicine, and maps ethical challenges stemming from those. Finally, the authors lay out how digital twins may change and challenge the future practice of medicine.

See Iqbal, Krauthammer and Biller-Andorno, The Journal of Law, Medicine & Ethics

Fig 2. Iqbal et al. © 2022 The Authors — Fig 2. Digital Twins have three user groups: Healthcare Providers, MedTech and Pharma Industry and Individuals. Industry is currently leading the other groups in adoption.. Iqbal et al. © 2022 The Authors

Back to news overview

Unterseiten

Support of applicants for the SNSF Professorial Fellowship / SNSF Starting Grant in the field of "Quantitative Biomedicine"
The Krauthammer Group Develops Explainable Deep Learning Model for Predicting Disease Activity in Joint Disorders
The Krauthammer group and collaborators develop advanced AI model to predict disease risk from multimodal data
In collaboration, the Joller group and the Krauthammer group reveal the regulatory role of tissue-specific Tregs in autoimmune diseases

Department of Quantitative Biomedicine

Quicklinks und Sprachwechsel

Main navigation

18.11.2022Michael Krauthammer and collaborators publish a perspective paper on the use and ethics of Digital Twins in medicine

The Use and Ethics of Digital Twins in Medicine

Unterseiten